Trial intelligence / Profile preview

Forced Fluid Removal vs. Usual Care in AKI with Fluid Overload

NCT02458157Phase 4Terminated

Sponsor
Nordsjællands Hospital
Start
Oct 2015
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of furosemide in acute kidney injury (AKI), Fluid overload, sponsored by Nordsjællands Hospital. Started Oct 2015; status: terminated.

02

Drugs

furosemide
03

Conditions

acute kidney injury (AKI)Fluid overload

Beyond the preview

Go deeper on NCT02458157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02458157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call